FIERCEPHARMA AND FIERCEBIOTECH PRESENT:
Medical Affairs Strategic Summit East
Medical affairs plays a pivotal role in communicating with external experts and clinicians, and is key to identifying unmet medical needs, raising awareness with clinicians, and providing valuable feedback and insights that can better inform an organization’s development strategy. After years of proven success, the Medical Affairs Strategic Summit (MASS) East returns in a virtual setting to serve as an educational platform to provide a holistic view of medical affairs, allowing your organization to develop a unified scientific voice and ultimately help position your team as a strategic and credible customer-facing partner in today’s healthcare landscape.
*Please note registration is complimentary for professionals from pharmaceutical, biotech, and medical device organizations. To register, please fill out the registration form. Once submitted, someone from our team will review your registration and approve it accordingly. Please note that you will not have immediate access to the virtual event. Once approved, you will receive an email with your login information.
FIVE FOCUS AREAS FOR 2020






MONDAY, JUNE 1
LAUNCH READINESS
10:15AM ET
Panel Discussion: Explore Launch Planning for Organizations of Varying Sizes
11:10AM ET
Leverage Online Discussion Platforms for Optimal Stakeholder Engagement
12:00PM ET
Panel Discussion: Streamline Efficiencies and Improve Techniques to Build and Run Advisory Boards
12:55PM ET
Panel Discussion: How Field Medical Can Help Prepare the Market for a New Drug Launch

TUESDAY, JUNE 2
MEDICAL AFFAIRS STRATEGY
10:15AM ET
The Evolution of Medical Affairs: Playing a Leading Role in the Product Lifecycle Within the Healthcare Ecosystem
11:10AM ET
Integrate HEOR into the Medical Affairs Product Strategy
12:00PM ET
Panel Discussion: Discuss the Benefits of Engagement from the Medical Affairs Team Early in the Product Lifecycle

WEDNESDAY, JUNE 3
MEDICAL OPERATIONS & TECHNOLOGY
10:15AM ET
Determine next steps following the development of your medical strategy
10:55AM ET
Improving Lives by Harnessing the Power of Patient Journey Complete Encounters
11:45AM ET
Leveraging Technology to Standardize Medical Grants Programs and Digital Outcomes
12:25PM ET
Review the Impact of Real-World Evidence on Medical Affairs Strategy

THURSDAY, JUNE 4
MSL & FIELD STRATEGY
10:15AM ET
The Ever-Elusive Balance of Quantity vs. Quality in MSL Goals and Metrics
10:55AM ET
Panel Discussion: Build the MSL Career Path with a Focus on Facilitating Team Retention
12:00PM ET
Panel Discussion: Dissemination of Off Label Information in a Compliant Manner

FRIDAY, JUNE 5
INVESTIGATOR-INITIATED TRIALS
10:15AM ET
Panel Discussion: Share Best Execution Practices for IITs in Different Therapeutic Areas
11:10AM ET
Effectively Demonstrate the Value of Investigator-Sponsored Research to Internal Leadership
12:00PM ET
Establish an Efficient and Compliant Process for Assessing the Fair Market Value (FMV) of IIT Budgets
12:40PM ET
Deep Dive into Best Practices for Negotiating Contracts to Improve Study Start-Up
EVENT HIGHLIGHTS
- Discover how innovative technologies like artificial intelligence and real-world evidence platforms can impact medical affairs operations
- Streamline efficiencies and improve techniques to build and run advisory boards, engage with KOLs, and collect and leverage insights to drive value for external stakeholders
- Look at data mining activities that enhance customer engagement, and the new and improved ways to effectively collect and synthesize MSL insights
- Look into medical strategy improvements from early engagement in the product lifecycle to product launch effortstherapies
- Explore approaches to improve internal approval processes for new investigator-initiated studies, determine fair market value, and manage the study life cycle while staying compliant with current regulations
Who Should Attend:
This conference is designed for representatives from pharmaceutical, biotechnology, and medical device organizations with responsibilities in the following areas:
|
|